// App-Quantinova.ai

Su1870 : THE INCIDENCE OF CARDIOVASCULAR EVENTS IN PATIENTS WITH Crohn's DISEASE TREATED WITH VEDOLIZUMAB AND ANTI-TNF THERAPIES

Researchers

Presenter

  • Mark T. Osterman

Principal Investigators

  • Remo Panaccione

  • Anita Afzali

  • Xue Song

  • Nianwen Shi

  • Yao Ding

  • Anthony Wang

Medical Centers

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • University of Washington- Harborview Medical Center, Seattle, Washington, United States

  • University of Maryland Medical School, Baltimore, Maryland, United States

  • University of Calgary, Calgary, AB, Canada

Locations

  • United States

  • Canada

Companies

  • AbbVie Inc.

  • Truven Health Analyt

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved